Clinic
Moore Care LLC
Moore Care LLC was paid $912K by Medicaid between Jan 2018 and Nov 2024, across 17 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 52% of everything it billed.
33Billing provider infoMOORE CARE LLC
MOORE, OK 73160
MOORE, OK 73160
33aNPI1104379148assigned 07/26/2016
33bProvider typePrimary Care Clinic/Center
28Total paid$912K
24GClaims11,059
24DCodes billed17
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Oklahoma
Rank by total paid#18 of 86
Median peer was paid$175K
This provider vs. median5.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 837 | $50K | |
| 2019 | 1,333 | $90K | |
| 2020 | 1,464 | $90K | |
| 2021 | 1,696 | $156K | |
| 2022 | 1,821 | $174K | |
| 2023 | 2,095 | $186K | |
| 2024incomplete | 1,813 | $167K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 52% | 4,669 | 4,271 | $472K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 4,556 | 4,120 | $305K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.3% | 516 | 516 | $48K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 4.1% | 93 | 92 | $37K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.8% | 113 | 113 | $16K |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 1.6% | 47 | 47 | $15K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 1.0% | 23 | 23 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 763 | 741 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 32 | 32 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 31 | 31 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 49 | 49 | $791.37 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 16 | 16 | $682.97 |
5 more codes
| 99335 | <1% | 75 | $567.06 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 31 | $547.74 |
| 90756 | <1% | 15 | $300.80 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 16 | $272.01 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $216.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFINCH, COREY (OWNER)